Kubota Pharmaceutical Holdings Co., Ltd. provided consolidated earnings guidance for the year ending December 31, 2022. For the year, the company expected operating loss of JPY 2,000 million, net loss of JPY 2,000 million or JPY 43.61 per basic share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69 JPY | 0.00% | -2.82% | -13.75% |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 24.83M | |
+31.37% | 588B | |
-2.83% | 364B | |
+20.49% | 326B | |
+5.39% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.89% | 167B | |
+0.20% | 161B |
- Stock Market
- Equities
- 4596 Stock
- News Kubota Pharmaceutical Holdings Co., Ltd.
- Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022